NanoScent develops device to detect Covid-19

In the latest interview by CTECH, NanoScent's CEO, Oren Gavriely, shares insights to the company developments and the greater purpose of scent recognition technology in the healthcare industry.

“Different diseases can be detected by smell, in the same way that some people who suffer from epilepsy use dogs who can ‘smell’ or predict a seizure,” Gavriely said. “Similarly to when cheese goes bad, there’s different activities going on within the organism that can create a unique odor pattern, but serve as an early indicator. NanoScent wants to capture this odor by using a very scalable solution to help provide early indications for different diseases.”